TREM-1 has emerged as a critical regulator of various pathophysiological processes, including angiogenesis, pneumonia, cardiovascular diseases, carcinogenesis, wound healing, etc. The biological functions of TREM-1 are modulated by its binding affinity to specific ligands, making it an attractive target for drug development. This evidence concerns the gene TREM1 and susceptibility to pneumonia measurement.